Gys1 - OmicsDI

Show results for

Unknown (85)
Genomics (15)
Transcriptomics (14)
Proteomics (6)
Metabolomics (1)

Organisms

Homo sapiens (9)
Mus musculus (4)
Caenorhabditis elegans (3)
Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Chlamydomonas reinhardtii (2)
Clostridium perfringens (2)
Dengue virus (2)
Eukaryota (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Kamptonema sp. (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mus musculus (2)
Mycobacterium tuberculosis (2)
Bacillus thuringiensis (1)
Spodoptera frugiperda (1)
Equus caballus (1)
Sus scrofa (1)
Rattus rattus (1)

Organisms

Homo sapiens (4)
Mus musculus (3)
Equus caballus (1)
Sus scrofa (1)

Repository

ENA (11)
biostudies-arrayexpress (8)
geo (7)
EGA (3)
iProX (3)
pride (2)
MassIVE (1)
MetaboLights (1)

Tissue

Malignant cell (2)
Ovary cancer cell (1)
Ovary cancer cell line (1)

Disease

Ovarian cancer (2)

Technology Type

Gel-based experiment (2)
Mass Spectrometry (2)
Illumina HiSeq 2000 (1)
Mass spectrometry (1)

Instrument Platform

Q Exactive HF-X (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (4)
2024 (4)
2009 (3)
2026 (3)
2010 (2)
2013 (1)
2012 (1)
2008 (1)
2021 (1)
2017 (1)

Metabolite Name

Geranyl pp (1)
FAHFA (18:1/18:2) (1)
N4-phenyl-3,5-dimethylisoxazole-4-sulfonamide (1)
Cer-EODS (d22:0/12:0-O-16:0) (1)
6-bromo-3-(2-phenylethanhydrazonoyl)-2H-chromen-2-one (1)
4-Hydroxy-3-methoxymandelic acid (1)
Cyclic adenosine diphosphate-ribose (1)
2,3-Bisphospho-D-glyceric acid (1)
N1-morpholinocarbothioylbenzamide (1)
FAHFA (18:0/20:2) (1)
SM (d14:1/16:0) (1)
FAHFA (16:1/18:3) (1)
OxPE (18:1-20:5+1O(1Cyc)) (1)
PE (16:0/18:3) (1)
FAHFA (16:0/18:2) (1)
D-Sedoheputulose 7-phosphate (1)
5-(tert-butyl)-3-[(2-cyanoacetyl)amino]thiophene-2-carboxamide (1)
FAHFA (18:2/20:4) (1)
3-(benzoylamino)benzyl benzoate (1)
FAHFA (18:1/20:3) (1)
2-(4-chlorophenyl)-1H-indole-3-carbaldehyde oxime (1)
PE (16:0/18:2) (1)
SM (d14:1/18:0) (1)
SM (d14:1/20:0) (1)
3'-Dephospho-CoA (1)
Prostaglandin E1 Ethanolamide (1)
¦Á-Lactose (1)
Tetrahydroaldosterone (1)
2-[6-(1H-benzo[d]imidazol-2-yl)-2-pyridyl]-1H-benzo[d]imidazole (1)
1,5,8-Trihydroxy-9-oxo-9H-xanthen-3-yl beta-D-glucopyranoside (1)

First Public Date

2025 (4)
2024 (2)
2026 (1)
2023 (1)
2022 (1)
2021 (1)
2017 (1)

Study type

ChIP-chip by tiling array (3)
Transcription profiling by array (3)
RNA-seq of coding RNA (2)

Release Date

2025 (15)
2023 (15)
2024 (13)
2021 (7)
2020 (6)
2018 (6)
2012 (4)
2009 (4)
2022 (4)
2010 (3)
2017 (3)
2014 (3)
2008 (2)
2016 (2)
2015 (2)
2013 (1)
2026 (1)
2019 (1)
2011 (1)

Lab affiliation

Sun yat-sen university cancer center (2)

Tags

xref:PubMed:39962227 (1)
xref:PubMed:41831133 (1)
xref:PubMed:34922943 (1)
xref:PubMed:39766885 (1)
xref:PubMed:40210982 (1)
xref:PubMed:41363704 (1)
xref:PubMed:41035048 (1)

Previous page
1 / 13
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 13
Next page

Sort by:

Relevance

Page size

The IP-MS analysis of anti-p53 and anti-GYS1 in ovarian clear cell carcinoma

Ovarian cancer (OC) is a highly fatal and refractory malignancy affecting women, with platinum resistance remaining a major clinical dilemma. Ovarian clear cell carcinoma (OCCC) frequently exhibits increased platinum refractoriness than the other OC subtypes, accompanied by heightened glycogen that ...

ORGANISM(S): Homo sapiens (Human)

2026-09-14 | PXD057878 | Pride